Blood-based diagnostics for Alzheimer's Disease
阿尔茨海默病的血液诊断
基本信息
- 批准号:9231053
- 负责人:
- 金额:$ 6.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAlzheimer&aposs DiseaseAmyloid beta-ProteinAnimal ModelBiochemicalBiologicalBiological AssayBlindedBloodBlood TestsBrainBrain InjuriesBusinessesCause of DeathCerebrospinal FluidCerebrumChemical StructureClinicalCorrelation StudiesDementiaDepositionDetectionDevelopmentDiagnosisDiagnosticDiseaseDisease ProgressionEarly DiagnosisElderlyEvaluationEventGoalsHealthHumanIn VitroIndividualInstitutionKnowledgeLaboratory DiagnosisLeadLiquid substanceMedicalMole the mammalMonitorMutationNerve DegenerationPatientsPersonsPhasePlasmaPopulationPredictive ValuePrion DiseasesPrionsPropertyProteinsReproducibilitySamplingSecureSensitivity and SpecificitySmall Business Technology Transfer ResearchSpecificityStagingStructureTechniquesTechnologyTestingTimeTissuesTransgenic AnimalsTransgenic MiceUrineValidationWorkabeta accumulationabeta oligomerauthoritybaseclinical Diagnosisdesigndisease diagnosisexperiencefamilial Alzheimer diseasehigh riskmild cognitive impairmentmouse modelnervous system disorderpolymerizationpre-clinicalprogramsprotein misfoldingprotein misfolding cyclic amplificationresearch study
项目摘要
DESCRIPTION (provided by applicant): This proposal is for a phase I/II fast track project for the STTR program with the main goal to develop a blood test for Alzheimer's disease (AD) diagnosis. AD is the most common dementia in the elderly population and one of the leading causes of death in the developed world. One of the main problems in AD is the lack of an early, sensitive and objective laboratory diagnosis to identify individuals that will develop the disease before substantial brain damage. Compelling evidences point that the hallmark event in AD is the misfolding, aggregation and brain accumulation of amyloid-beta (Aβ) protein. Aβ aggregation follows a seeding-nucleation mechanism and involves several intermediates, including soluble oligomers and protofibrils. Recent evidence has shown that Aβ oligomers are circulating in biological fluids and these structures appear to be key for inducing brain degeneration in AD. Our working hypothesis is that detection of misfolded Aβ oligomers circulating in blood may be the basis for an early biochemical diagnosis for AD. Our approach is to use the functional property of misfolded oligomers of being capable to catalyze the polymerization of the monomeric protein as a way to detect them. We have recently invented the protein misfolding cyclic amplification (PMCA), which represent a platform technology to detect very small quantities of seeding-competent misfolded oligomeric proteins associated with various protein misfolding diseases. Currently, PMCA has been adapted to detect misfolded prion protein implicated in prion diseases in various biological fluids, including blood and urine and more recently soluble Aβ oligomers in cerebrospinal fluid of AD patients. The major goal of this project is to adapt the PMCA technology for specific and highly sensitive detection of misfolded Aβ oligomers in human blood, perform studies of specificity and sensitivity using large number of samples and evaluate the utility of Aβ-PMCA for pre-clinical identification of people in the way to develop AD. The results generated in this project may lead to the first biochemical test for blood-based diagnosis of AD. The studies included in this project will constitute the basis for regulatory approval of the test that Amprion will commercialize.
描述(由申请人提供):这项提案是针对STTR项目的I/II阶段快速通道项目,主要目标是开发用于阿尔茨海默病(AD)诊断的血液测试。AD是老年人口中最常见的痴呆症,也是发达国家的主要死亡原因之一。阿尔茨海默病的主要问题之一是缺乏早期、敏感和客观的实验室诊断,以在大脑实质性损伤之前识别将发展为该病的个体。令人信服的证据表明,AD的标志性事件是淀粉样β蛋白(Aβ)的错误折叠、聚集和脑积聚。β聚集遵循种子成核机制,涉及几个中间体,包括可溶低聚物和原纤维。最近的证据表明,Aβ寡聚体在生物体液中循环,这些结构似乎是诱导AD大脑退化的关键。我们的工作假设是,血液中循环的错误折叠的Aβ寡聚体的检测可能是AD早期生化诊断的基础。我们的方法是利用错误折叠的低聚物能够催化单体蛋白质聚合的功能特性作为检测它们的一种方法。我们最近发明了蛋白质错误折叠循环扩增(PMCA),它代表了一种平台技术,可以检测与各种蛋白质错误折叠疾病相关的非常少量的种子能力错误折叠低聚蛋白。目前,PMCA已被用于检测各种生物体液中与Pron病有关的错误折叠的Prion蛋白,包括血液和尿液,以及最近在AD患者脑脊液中的可溶性Aβ寡聚体。本项目的主要目标是将该技术应用于人类血液中错误折叠的Aβ寡聚体的特异性和高灵敏检测,使用大量样本进行特异性和敏感性研究,并评估Aβ-PMCA在AD患者临床前鉴定中的应用。该项目产生的结果可能导致第一个基于血液的AD诊断的生化测试。该项目中包括的研究将构成监管部门批准Amprion将商业化的测试的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAUDIO SOTO其他文献
CLAUDIO SOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAUDIO SOTO', 18)}}的其他基金
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
α-突触核蛋白聚集体的充分表征的多态性变体的生产和分布
- 批准号:
10706583 - 财政年份:2022
- 资助金额:
$ 6.47万 - 项目类别:
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
α-突触核蛋白聚集体的充分表征的多态性变体的生产和分布
- 批准号:
10549216 - 财政年份:2022
- 资助金额:
$ 6.47万 - 项目类别:
Comprehensive diagnosis of Alzheimer's disease by detection of misfolded oligomers in biological fluids
通过检测生物体液中错误折叠的寡聚物来全面诊断阿尔茨海默病
- 批准号:
9766691 - 财政年份:2019
- 资助金额:
$ 6.47万 - 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
- 批准号:
8450044 - 财政年份:2012
- 资助金额:
$ 6.47万 - 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
- 批准号:
8299342 - 财政年份:2012
- 资助金额:
$ 6.47万 - 项目类别:
Absorption, Metabolism and Biodistribution of Prions after Oral Ingestion
口服摄入后朊病毒的吸收、代谢和生物分布
- 批准号:
8439892 - 财政年份:2012
- 资助金额:
$ 6.47万 - 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
- 批准号:
8829300 - 财政年份:2012
- 资助金额:
$ 6.47万 - 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
- 批准号:
8641401 - 财政年份:2012
- 资助金额:
$ 6.47万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 6.47万 - 项目类别:
Directed Grant